Even though APC is not an actionable gene for CRC treatment, in vitro studies have shown that small‐molecule inhibitors targeting APC truncated proteins either restore the WNT/β‐catenin signaling pathway or cause cytotoxicity.25, 26. The gene discussed is APC; the disease is colorectal carcinoma.